Search Results
240 results
Your search is now limited to «Excipients» expert search.
ClinicalTrials.gov 02/15/2019 11:26
Condition : Hypoglycemia Interventions : Drug: Glucagon RTU Injection; Other: Vehicle for Glucagon RTU Injection Sponsor : Xeris Pharmaceuticals Recruiting.
More from ClinicalTrials.gov:
Market Exclusive 02/15/2019 07:08
SENSIENT TECHNOLOGIES CORPORATION (NYSE:SXT) Files An 8-K Results of Operations and Financial ConditionITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On February 15, 2019, Sensient Technologies Corporation issued a press release disclosing its results of operations for its quarter and year ended December 31, 2018, and its financial condition at that date. The press release […]. The post SENSIENT TECHNOLOGIES CORPORATION (NYSE:SXT) Files An 8-K Results of Operations and Financial Condition appeared first on Market Exclusive .
More from Market Exclusive:
PR Newswire 02/14/2019 11:45
DUBLIN, Feb. 14, 2019 /PRNewswire/ -- The "Flow Imaging Microscopy/Dynamic Image Analysis Market by Sample Type (Biologics, Small Molecules, Excipient), Sample Dispersion, End User (Biotechnology Companies, Pharmaceutical Companies, CRO, CMO) - Global Forecast to 2023" report has been...
More from PR Newswire:
PharmTech.com 02/14/2019 10:00
Pharmaceutical Technology spoke with Lisa Crandall, MS, associate director CMC Project Management, and Peter Angus, PhD, director of Pharmaceutical Sciences, at Velesco Pharma, which provides a full range of stability testing of API and drug products, about best practices in stability testin.
More from PharmTech.com:
Seeking Alpha 02/14/2019 09:14
Avantor, which New Mountain Capital acquired from Covidien Inc. in August 2010, provides products and services to clients in the biopharma, healthcare, educatio.
More from Seeking Alpha:
Business Wire 02/12/2019 16:05
Revance uses a unique proprietary peptide excipient technology to create novel, differentiated therapies.
More from Business Wire:
(MENAFN - News Services Group (NSG)) CAMBRIDGE, Mass. and OSAKA, Japan -Tuesday 12 February 2019 [ AETOS Wire ] ( BUSINESS WIRE )-- Takeda Pharmaceutical Company Limited (TSE:45...
More from Middle East North Africa Financial Network (MENAFN):
Intellectual Property Watch 02/08/2019 09:59
A ground-breaking new high-tech system to catch falsified medicines in the supply chain in Europe went into effect today, allowing prescription medicines to undergo verification for authenticity before reaching patients.
More from Intellectual Property Watch:
3BL Media 02/08/2019 04:30
DESCRIPTION:. From Europe and Asia to the Americas, MilliporeSigma i employees gave back to their local communities in more ways than one during SPARK Week, October 13-21, 2018. Not only did they teach Curiosity Labs™ lessons and host site tours, but they also brought science education to a low-income village and an orphanage, impacting thousands of students by providing them with hands-on experiments to spark their curiosity in science. Teaching Flavors and Fragrances at Technorama OpenLab in Switzerland. Technorama is one of the largest and most renowned science centers in the world, and one of the company’s signature partners. MilliporeSigma’s Buchs, Switzerland team invited 50 high school students from a local public school to the science.
GlobeNewswire 02/07/2019 07:30
CINCINNATI, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that following the successful release of the Lyo-Ready qPCR Mix, Meridian is proud to introduce its next-generation lyophilization-ready mixes for one-step RT-qPCR.
More from GlobeNewswire:
ACN Newswire 02/06/2019 20:56
CLEVELAND, Ohio, Feb 7, 2019 - (ACN Newswire) - The Lubrizol Corporation announces its LifeSciences business will feature a new medical device applications lab. LifeSciences has invested significantly to expand its global development and manufacturing facilities, and the latest investment is a new state-of-the-art medical device applications lab in Brecksville, Ohio. This lab features applications testing, small-scale compounding as well as injection molding for long-term implantables. The 1,800-square foot facility will also focus on accelerated R&D, from polymers to device scale up and testing in a short period of time. The medical device applications lab is yet another substantial piece of LifeSciences' full-service capabilities. These c.
More from ACN Newswire:
Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for.
More from Global Banking & Finance Review:

Chemicals - Agricultural

Chemicals - Industrial

Business Issues

Companies - Public

Companies - Venture Funded

Commodity Prices

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications